JAKAFI
NDC 50881-025 · Incyte Corporation
Generic nameruxolitinib
Dosage formTABLET
RouteORAL
Active ingredient(s)RUXOLITINIB
Strength25 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]
Marketing categoryNDA
Packages
50881-025-60 — 60 TABLET in 1 BOTTLE, PLASTIC (50881-025-60)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50881-005 — ruxolitinib, 50881-010 — ruxolitinib, 50881-011 — ruxolitinib, 50881-015 — ruxolitinib, 50881-020 — ruxolitinib, 50881-022 — ruxolitinib, 50881-033 — ruxolitinib, 50881-044 — ruxolitinib, 50881-055 — ruxolitinib